Author name: GINZA NOA CLINIC

Doctors consider immunotherapy when stomach cancer cannot be removed surgically or has spread, and the tumor’s test results support a […]

Immunotherapy works for relatively few pancreatic cancer patients because most tumors do not contain enough active, cancer-fighting T cells for

Doctors choose a liver cancer immunotherapy regimen by weighing the expected cancer control against liver function, bleeding risk, and immune-related

Tumor genetics matter because they affect how easily the immune system can recognize colorectal cancer. Tumors with defective DNA mismatch

Triple-negative breast cancer is the subtype with the clearest proven benefit from checkpoint immunotherapy. Pembrolizumab can improve survival in eligible

Editorial evidence update — 10 October 2026. This revision corrects study interpretation, numerical denominators and regulatory distinctions. It is an

Editorial evidence update — 10 October 2026. This revision corrects study interpretation, numerical denominators and regulatory distinctions. It is an

Editorial evidence update — 10 October 2026. This revision corrects study interpretation, numerical denominators and regulatory distinctions. It is an

Editorial evidence update — 10 October 2026. This revision corrects study interpretation, numerical denominators and regulatory distinctions. It is an

Editorial evidence update — 10 October 2026. This revision corrects study interpretation, numerical denominators and regulatory distinctions. It is an